Paul Streck

Chief Tech/Sci/R&D Officer at PEPGEN INC.

Net worth: 17 031 $ as of 2026-05-30

62 year

Health Technology

Consumer Services

Profile

Paul D.
Streck is Executive VP, Head-Research & Development at PepGen Inc. since 2024.
Former roles include Director-Marketing at Amgen USA, Inc. (2006–2007), Chief Medical Officer at Insmed, Inc. (2017–2019), Chief Medical Officer & SVP-Clinical Development at Arena Pharmaceuticals, Inc. (2020–2022), Group Vice President at Shire Plc (2013–2015), Group Vice President at GSK Plc, Chief Medical Officer at Lundbeck Seattle BioPharmaceuticals, Inc., and Chief Medical Officer at Albireo Pharma, Inc. Education includes undergraduate studies at Rutgers State University of New Jersey, graduate studies at Sidney Kimmel Medical College, and an MBA from The Fuqua School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PEPGEN INC. 0.02%	2026-03-30	11,354 ( 0.02% )	17 031 $	2026-05-30

Paul Streck active positions

Companies	Position	Start
PEPGEN INC.	Chief Tech/Sci/R&D Officer	2024-08-19

All active positions of Paul Streck

Former positions of Paul Streck

Companies	Position	End
ARENA PHARMACEUTICALS	Chief Tech/Sci/R&D Officer	2022-03-10
INSMED INCORPORATED	Chief Tech/Sci/R&D Officer	2019-01-17
SHIRE	Corporate Officer/Principal	2015-10-31
Amgen USA, Inc. Amgen USA, Inc. BiotechnologyHealth Technology Manufactures biological products	Sales & Marketing	2007-09-30
ALBIREO PHARMA, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Paul Streck's experience

Training of Paul Streck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Streck's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Insmed, Inc. Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases	Health Technology
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases	Health Technology
Sidney Kimmel Medical College Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Fuqua School of Business The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders	Health Technology
Amgen USA, Inc. Amgen USA, Inc. BiotechnologyHealth Technology Manufactures biological products	Health Technology
PepGen Inc. PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases	Health Technology